- Home
- TCRX vs KBSX Comparison
TCRX vs KBSX Comparison
Compare TCRX & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- KBSX
- Stock Information
- Founded
- TCRX 2018
- KBSX 1976
- Country
- TCRX United States
- KBSX Taiwan
- Employees
- TCRX N/A
- KBSX N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- KBSX Recreational Games/Products/Toys
- Sector
- TCRX Health Care
- KBSX Consumer Discretionary
- Exchange
- TCRX Nasdaq
- KBSX Nasdaq
- Market Cap
- TCRX 64.1M
- KBSX 65.8M
- IPO Year
- TCRX 2021
- KBSX N/A
- Fundamental
- Price
- TCRX $0.98
- KBSX $1.45
- Analyst Decision
- TCRX Strong Buy
- KBSX
- Analyst Count
- TCRX 7
- KBSX 0
- Target Price
- TCRX $8.50
- KBSX N/A
- AVG Volume (30 Days)
- TCRX 1.1M
- KBSX 8.7K
- Earning Date
- TCRX 11-12-2025
- KBSX 11-19-2025
- Dividend Yield
- TCRX N/A
- KBSX N/A
- EPS Growth
- TCRX N/A
- KBSX N/A
- EPS
- TCRX N/A
- KBSX N/A
- Revenue
- TCRX $8,423,000.00
- KBSX $44,890,395.00
- Revenue This Year
- TCRX $255.18
- KBSX N/A
- Revenue Next Year
- TCRX N/A
- KBSX N/A
- P/E Ratio
- TCRX N/A
- KBSX N/A
- Revenue Growth
- TCRX N/A
- KBSX 27.47
- 52 Week Low
- TCRX $0.96
- KBSX $1.26
- 52 Week High
- TCRX $4.94
- KBSX $15.48
- Technical
- Relative Strength Index (RSI)
- TCRX 28.55
- KBSX 36.48
- Support Level
- TCRX $0.96
- KBSX $1.32
- Resistance Level
- TCRX $1.25
- KBSX $1.50
- Average True Range (ATR)
- TCRX 0.13
- KBSX 0.04
- MACD
- TCRX -0.02
- KBSX -0.00
- Stochastic Oscillator
- TCRX 4.00
- KBSX 52.38
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About KBSX FST Corp. Ordinary Shares
FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.